<DOC>
	<DOCNO>NCT02720328</DOCNO>
	<brief_summary>The purpose study investigate preventability serious adverse drug reaction ( ADRs ) relate use direct oral anticoagulant ( DOACs ) . The investigator also aim identify underlying cause preventable ADRs . The endpoint measurement compare group patient take vitamin-K antagonist ( VKAs ) . For purpose , protocol prospective observational study develop . The study approve Ethics Committee CHU UCL Namur ( site Godinne ) Cliniques Universitaires Saint-Luc . Patients admit emergency department two teaching hospital thrombotic bleed event DOAC VKA include . After comprehensive medication history , appropriateness prescribing evaluate , use adapt version Medication Appropriateness Index . Causality , severity preventability adverse event assess two pharmacist two hematologist use predefined scale . Second , case serious preventable ADRs , semi-structured interview perform general practitioner understand underlying cause medication error . Based result , risk-minimization strategy specifically target problem encounter clinical practice propose .</brief_summary>
	<brief_title>Prevalence Causes Preventable Serious Adverse Drug Reactions Related Use Oral Anticoagulants</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Embolism Thrombosis</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Admitted emergency department Presenting thrombotic bleeding event Prescribed NOAC ( rivaroxaban , dabigatran etexilate apixaban ) VKA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>